Urology
Become a Member Today!
Register
Email
Password
Remember me
Forgot your Password?
Invite Code?
Home
General Urology
Messages
Conferences
Jobs
Newsletters
My Library
Topics in
Urology
Adrenal Glands
Basic Science/Genetics
Bladder
Clinical Pharmacology
Economics of Medicine
Endocrine
Erectile Dysfunction
Infections/STDs
Infertility
Kidney
Laparoscopy
Oncology
Pediatric Urology
Penis/Urethra
Popular Press
Prostate
Radiology/Diagnostics
Stone Disease
Surgical Technique
Testis/Scrotum
Transplantation
Ureteral Disease
Voiding Dys/Incontinence
Help
Resource Center
RSS News Feeds
Send Newsletter
to a Friend
Sponsor
Cancer Science:
A Shot in the Arm for Prostate Cancer
Sara Hartley, MDLinx Oncology
Clinical Trial Watch:
Gene Therapy Trial Seeks Prostate Ca Patients
Tracy Hampton, PhD, MDLinx Oncology
See all
Article Summary
Click the title below to leave the MDLinx Network and go to the Journal's Website
Identification of ETS-like transcription factor 4 as a novel androgen receptor target in prostate cancer cells
Oncogene, 05/13/08
Print
Email This Article
Save in My Library
Free Abstract
Makkonen H et al. - ELK4 is a direct AR target in prostate cancer cells. Androgens may thus contribute to the growth of prostate cancer via influencing ELK4 levels.
--- ONCOLOGY TOP ARTICLES ---
Receive free subspecialty "5-minute updates" via email
Phase II study of fulvestrant (faslodex) in castration resistant prostate cancer
The Prostate, 07/14/08
Docetaxel and bortezomib downregulate Bcl-2 and sensitize PC-3- Bcl-2 expressing prostate cancer cells to irradiation
World Journal of Urology, 07/07/08
Survival following primary androgen deprivation therapy among men with localized prostate cancer
JAMA, 07/14/08
...All of Oncology
Sponsor
--- PROSTATE TOP ARTICLES ---
Receive free subspecialty "5-minute updates" via email
Phase II study of fulvestrant (faslodex) in castration resistant prostate cancer
The Prostate, 07/14/08
Docetaxel and bortezomib downregulate Bcl-2 and sensitize PC-3- Bcl-2 expressing prostate cancer cells to irradiation
World Journal of Urology, 07/07/08
Survival following primary androgen deprivation therapy among men with localized prostate cancer
JAMA, 07/14/08
...All of Prostate
Read a Different Specialty
Allergy/Immunology
Anesthesiology
Cardiology
Dermatology
Drugs
Emergency Medicine
Endocrinology
ENT
Family Medicine
Gastroenterology
Hematology-Oncology
Infectious Disease
Internal Medicine
Nephrology
Neurology
OB/Gyn
Ophthalmology
Orthopedics
Pediatrics
Psychiatry
Pulmonology
Radiology
Rheumatology
Surgery
Urology
Profession Index
Dentist
Hospital Administrator
Nurse
Medical Students
Nurse Practitioner
Pharma/Drug Marketer
Pharmacist
Physician
Physician Assistants
Article Search
Keyword:
Search:
All MDLinx
AllergyImmunoLinx
AnesthesiaLinx
DentistLinx
DermLinx
DrugLinx
EmergencyMDLinx
EndoLinx
ENTLinx
FamilyMDLinx
GILinx
HeartLinx
HemeOncLinx
HospitalAdminLinx
IDLinx
InternalMDLinx
MedStudentLinx
NephrologyLinx
NeurologyLinx
NPLinx
NurseLinx
ObGynLinx
OphthoLinx
OrthoLinx
PALinx
PatientLinx
PediatricLinx
PharmacistLinx
PsychLinx
PulmonologyLinx
RadiologyLinx
RheumatologyLinx
SurgeryLinx
UrologyLinx
Published within:
Past Month
Past 3 Months
Past Year
Sort By:
Date
Relevance
Sponsor
About MDLinx
|
Contact
|
Advertise with MDLinx
|
Site Map
|
Privacy Policy
|
Terms of Use
|
Sign Up For Newsletters
|
Recommend this Site
English
|
Español
|
Français
|
Deutsch
|
中文
|
Руccкий
|
Norsk
|
Nederlands
|
Português
|
Italiano
©1999-2008 MDLinx, Inc.